AbbVie (NYSE:ABBV) reported positive topline Phase 3 results for risankizumab (SKYRIZI) in Crohn's disease. The company also ...
TD Cowen 46th Annual Health Care Conference March 3, 2026 1:50 PM ESTCompany ParticipantsCaroline Litchfield - Executive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results